SmartKem sells patent portfolio, discloses control weaknesses amid $17.8M non-operating loss

Filed May 20, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

Key Changes

• high

  Company sold its entire patent portfolio (138 granted patents across 17 families) to a third party in Q1 2026, retaining only 40 trade secrets. This fundamentally reshapes the IP asset base that previously anchored the business model.

  MD&A: Patent Portfolio Sale verify on EDGAR →
• high

  Management identified two material weaknesses in internal controls: one related to accounting for the equity line of credit transaction, and another from lack of independent control assessment during 2025 due to fiscal constraints.

  MD&A: Disclosure Controls verify on EDGAR →
• high

  Non-operating expenses swung to $16.8M loss in Q1 2026 from $1.0M income in Q1 2025, driven by $11.9M ELOC loss, $3.8M debt extinguishment charge, and $1.8M foreign exchange loss. These one-time charges materially distort reported results.

  MD&A: Non-Operating Expenses verify on EDGAR →